ArticleHuman brain mapping2026
BrainEnrich: Revealing Biological Insights for Imaging-Derived Phenotypes Through Transcriptomic Enrichment.
Article in Human brain mapping, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
While the field of imaging transcriptomics is evolving rapidly, several methodological challenges persist in functional enrichment analysis. Here, we introduce BrainEnrich, an R package that integrates whole-brain gene expression profiles from the Allen Human Brain Atlas (AHBA) with in vivo imaging-derived phenotypes (IDPs). By offering a suite of flexible association methods, aggregation strategies, comprehensive lists of predefined gene sets, and both competitive and self-contained null models, the package enables researchers to examine the spatial coupling between molecular profiles and IDPs at both group and individual levels. A novel feature of BrainEnrich is its individual-level enrichment analysis, which mapped individual IDPs onto a molecular coordinate framework, capturing the molecular signature of individual IDPs and enabling a deeper exploration of inter-individual variability. Its statistical power was examined through extensive simulation studies based on linear regression with different combinations of test statistics and null models. The results suggest that with appropriate null models, this approach effectively controlled Type 1 error while retaining sensitivity to detect associations between molecular profiles and phenotypic data. Two case studies were performed to demonstrate the utility of the package. In the group-level enrichment analysis, the effect size map of case-control comparison in cortical thickness of major depressive disorder patients was associated with molecular pathways such as synaptic signaling, lipid regulation, and steroid hormone balance, providing candidate molecular annotations for group-level IDPs. A separate case study found that synaptic gene set scores showed nominal associations with multiple cognitive measures, demonstrating its utility for individual-level molecular annotations to explore associations with phenotypic variables. Collectively, BrainEnrich provides a flexible framework for integrating macro-level IDPs with micro-level transcriptomic profiles for molecular contextualization of IDPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.